<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938097/" ref="ordinalpos=144&amp;ncbi_uid=3059920&amp;link_uid=PMC2938097" image-link="/pmc/articles/PMC2938097/figure/F6/" class="imagepopup">Fig. 6. From: Studies of Phosphoproteomic Changes Induced by Nucleophosmin-Anaplastic Lymphoma Kinase (ALK) Highlight Deregulation of Tumor Necrosis Factor (TNF)/Fas/TNF-related Apoptosis-induced Ligand <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> in ALK-positive Anaplastic Large Cell Lymphoma. </a></div><br /><div class="p4l_captionBody"><b>Schematic representation of TNF/Fas/TRAIL signaling pathway.</b> By analyzing our proteomics data, antibody microarray data, and our previously published binding protein data (20), a number of signaling pathways were identified, and the TNF/Fas/TRAIL signaling pathway is highlighted here. DEDD: Death effector domain-containing protein; DAXX: Death domain-associated protein 6.</div></div>